MVM Life Science Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
eyeBrain MedicalSep 2022SEC filingmedium confidence
BiotechNewport Beach, US
Davis Corley(Executive Officer)J. Andy Corley(Executive Officer, Director, Promoter)
Board seatEric BednarskiAkhilesh Pathipati· per SEC Form D · $67.6M raise · filed Sep 2022
Co-investorsVersant Venture AIV Holdings
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.